On the 21st September 2021, World Alzheimer’s Day, Alzheimer Scotland held their annual conference. It was a virtual event which was attended by people with dementia, carers, practitioners and other members of the public from all over Scotland. 

In the afternoon session, the SDRC was delighted to support a session titled Treating Dementia, What’s next and how do we get there? 

We know there are so much research ongoing across Scotland in all disciplines and types of dementia and brain health research. However, this session was particularly focussed on drug discovery and inspired by the approval of aducanumab in the US. We aimed to describe the process in which new treatments will be discovered for dementia. It also explained the journey from the discovery of a potential new treatment in labs through to clinical trials and beyond.

This Conference session was chaired by Alzheimer Scotland’s Director of Policy and Practice Jim Pearson, and featured four guest speakers, each with a different perspective of dementia research:

  • Miriam Scarpa, a lab scientist at the University of Glasgow
  • Terry Quinn, reader at the University of Glasgow (and SDRC Executive Committee member)
  • Eileen Penman, a research participant at the European Prevention of Alzheimer’s Disease (EPAD) consortium
  • Martin Rossor from Join Dementia Research

The recording of this session is available on the Alzheimer Scotland website, under Session 3.

We have also uploaded Miriam (part 1) (part 2) and Terry’s (part 1) (part 2) presentation from the day. 

 

 

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Read more SDRC Latest

    Edinburgh Dementia Prevention Summer School 2022

    Edinburgh Dementia Prevention are hosting a brain health summer school on Monday 26 September - Thursday 29 September 2022, at St Leonard's Hall, Edinburgh. It is is a 4-day interactive course designed principally for trainee and qualified clinicians, nurses and...

    NHS Research Scotland Neuroprogressive and Dementia Research Network Strategy Launch

    On 3rd December 2021, the NHS Research Scotland Neuroprogressive and Dementia Research Network (NRS NDN) launched a new strategy.  It sets out the Network's intention to involve, engage with, and support people with lived experience of neuroprogressive conditions or...

    Take part in a research study: Remote Cognitive Testing Survey

    The University of Oxford are looking for volunteers from Scotland to take part in a survey about the Impact of COVID-19 on cognitive testing  The Translational Neuropsychology Lab at the University of Oxford, are investigating the impacts of COVID-19 UK lockdown on...

    How COVID has Impacted Early Career Researchers: July 2020 Survey Findings

    You may be aware, since the start of the pandemic, the SDRC have been communicating with members on the impact of Covid on dementia research. At the start of lockdown, we ran a survey to find out how the pandemic has affected ECRs.  From this we created a report,...

    Research in the News: Football Heading and Dementia Risk

    Researchers Glasgow Brain Injury Research Group (GBIRG) led by Associate Professor Willie Stewart, have published their findings reporting a link between a footballers' outfield position and neurodegenerative risk.  Taking place at the University of Glasgow, as part...

    Scottish Neurological Research Fund 2021: Award Announcement

    We have produced a report based on the findings of how COVID-19 has impacted our members’ research- with particular focus on ECRs

    Research Recruitment Support for Primary Care Researchers

    The NRS Primary Care Network is the national primary care research network operating in Scotland. The network was established in 2002 as a framework to co-ordinate national research activity in primary care. The overall aim of the network is to increase the amount of...

    The launch Scottish Brain Health and Dementia Research Strategy

    Today (8 July 2021) sees the launch of the first Scottish Brain Health & Dementia Research Strategy. Prepared by Alzheimer Scotland, The Scottish Dementia Research Consortium and Brain Health Scotland, and endorsed by a broad range of national organisations, the...

    Celebrating Scottish Research Award Winners 2024

    We have produced a report based on the findings of how COVID-19 has impacted our members’ research- with particular focus on ECRs

    Aducanumab: Approval of new Alzheimer’s disease drug explained

    Aducanumab: Dr Terry Quinn explains approval of new Alzheimer's disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the treatment of...